ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
CP-COV03, a niclosamide-based oral antiviral drug, under study as possible cure for COVID-19 variants
December 08, 2021CP-COV03 is a broad-spectrum antiviral drug candidate, developed by Hyundai Bioscience to treat COVID-19. Its active pharmaceutical ingredient is niclosamide, an anthelmintic drug... -
Seegene introduces an exclusive diagnostic system for diagnosing COVID-19 variants at ECCMID
May 25, 2021Seegene Inc. , a biotechnology firm specializing in molecular diagnostics has once again been recognized for its unique system for diagnosing COVID-19 variants at this year's European Congress of Clinical Microbiology, the ECCMID.
Pharma Sources Insight January 2025
